RS
ONC

Rakuten Securities’s BeOne Medicines Ltd ONC Stock Holding History

Rakuten Securities’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.08K Sell
7
-1
-13% -$324 ﹤0.01% 613
2025
Q4 		$2.43K Buy
+8
New +$2.62K ﹤0.01% 604
2025
Q1 		– Sell
-8
Closed -$1.8K – 878
2024
Q4 		$1.8K Buy
+8
New +$1.64K ﹤0.01% 574

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Rakuten Securities's ONC Position: Q1 2026 in Review

Rakuten Securities reduced its BeOne Medicines Ltd (ONC) stake by 13% in Q1 2026, selling an estimated $324 and leaving 7 shares worth $2.08K. The position accounts for ﹤0.01% of the portfolio, ranked #613.

Rakuten Securities first reported a position in ONC in Q4 2024 and has held it in 3 quarters since. The position peaked at $2.43K in Q4 2025. 281 funds tracked by Wall St. Rank hold ONC as of Q1 2026.

  • Rakuten Securities held 7 shares of BeOne Medicines Ltd worth $2.08K as of Q1 2026.
  • Rakuten Securities sold 1 BeOne Medicines Ltd share in Q1 2026, an estimated $324.
  • BeOne Medicines Ltd made up ﹤0.01% of Rakuten Securities's portfolio in Q1 2026, its #613 holding.
  • Rakuten Securities first reported a position in BeOne Medicines Ltd in Q4 2024 and has held it in 3 quarters since.
  • Rakuten Securities's BeOne Medicines Ltd position peaked at $2.43K in Q4 2025.
  • 281 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2026.

Based on Rakuten Securities's 13F filing for Q1 2026, filed 1 May 2026.